PSR Direct Award A Notice - CAMHS ADHD Assessment tool

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

The decision makers where:

Brian Cranna - Director of Operations and Transformation

North Yorkshire and York Care Group(30/09/25), Jamie Todd - Director of Operations & Transformation

DTVF CAMHS, Adult Mental Health and Ridgeway Secure Inpatient Services

Care Group (30/09/25), Mel Woodcock - General Manager

North Yorkshire, York & Selby CAMHS & LD Services (30/09/25), James Graham -

General Manager Durham and Tees Valley Community CAMHS (30/09/25) Steven Smith and Claire Bestford Principle Finance Business Partners NYY and DTV. (30/09/25)

Liz Romaniak - Director of Finance, Estate and facilities - (20/10/25)

No Conflicts of interest where identified or declared.

Qbtech Ltd is the sole provider of QbTest, the only FDA Cleared, EMA registered

and CE Marked medical device available in the UK to objectively measure

Hyperactivity, Inattention and Impulsivity. QbTest is cleared for use as an aid in the

assessment and treatment evaluation of ADHD for those aged 6-60 years old.

Details of the FDA Clearances are: To aid in the clinical assessment of ADHD in

children (K040894); To aid in the clinical assessment of ADHD in adolescents and

adults (K122149); and: To aid in the evaluation of treatment interventions in patients

with ADHD (K133382). QbTest is the only ADHD test with NHS cost-efficiency d